PNEUMOCOCCAL INFECTIONS
Clinical trials for PNEUMOCOCCAL INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTIONS trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New infant vaccine tested to fight pneumonia
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called AFX3772, designed to protect healthy infants from serious pneumococcal infections like pneumonia. Researchers compared three different versions of the new vaccine to two existing, approved vaccines (Prevnar 13 and Prevnar 20) to see which wa…
Matched conditions: PNEUMOCOCCAL INFECTIONS
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:40 UTC
-
First human tests begin for new Pneumonia-Fighting vaccine
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new vaccine designed to protect against 13 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. It involved 310 healthy participants, from infants as young as 6 weeks to adults up to 49 years old. The main goal wa…
Matched conditions: PNEUMOCOCCAL INFECTIONS
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:17 UTC
-
Double-Shot defense: can a new vaccine strategy protect cancer patients from deadly infections?
Prevention CompletedThis study tested a two-vaccine strategy to prevent serious pneumococcal infections, like pneumonia, in adults with a type of blood cancer (DLBCL) who were receiving chemotherapy. Researchers wanted to see if giving two different vaccines in a specific order, and testing differen…
Matched conditions: PNEUMOCOCCAL INFECTIONS
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC